7 Analysts Assess Emergent BioSolutions: What You Need To Know
7 Analysts Assess Emergent BioSolutions: What You Need To Know
7位分析师评估 Emergent BioSolutions：你需要知道的一切
In the last three months, 7 analysts have published ratings on Emergent BioSolutions (NYSE:EBS), offering a diverse range of perspectives from bullish to bearish.
在过去三个月中，共有7位分析师对Emergent BioSolutions (NYSE:EBS)发表了评级，提供了从看好到看淡的各种不同观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
Analysts have recently evaluated Emergent BioSolutions and provided 12-month price targets. The average target is $8.0, accompanied by a high estimate of $8.00 and a low estimate of $8.00. This upward trend is evident, with the current average reflecting a 5.68% increase from the previous average price...
分析师最近对Emergent BioSolutions进行了评估并提供了12个月的价格...
登录免费看全文
登录/注册